The pharmaceutical industry is taking action after the Trump administration finalized a rule that would require drugmakers to publish list prices in television ads.

The Trump administration was warned that its policy changes undermining the Affordable Care Act would cause disruption to healthcare coverage and likely increase taxes, according to a leaked internal memo, first reported by Politico. CMS Administrator Seema Verma penned the memo in August 2018 and outlined how several policy changes could negatively impact the ACA market.

As Medicare for all continues to gain traction among American voters and more Democratic presidential nominees take up the platform, the American Medical Association has decided not to support such an initiative.

That’s the question David Freedman tried to answer in an article in The Atlantic, pointing out that the high cost of the U.S. healthcare system could come down to the patients themselves.

HHS, with the Departments of Labor and Treasury, has issued a new rule to expand the use of health reimbursement coverage, which provide tax-preferred funds for employees to buy their own insurance on the individual market.

BlackThorn Therapeutics, a clinical-stage neurobehaviorial health company, has raised $76 million in a Series B funding round, the company announced June 13.  

The sky-high costs of receiving medical care and the reality of asking for help to pay those bills are being highlighted by The Huffington Post in a series titled “Life and Death: Stories from Inside America’s GoFundMe Health Care System.”

The American Medical Association (AMA) has elected its new board of trustees for 2019-2020, with women physicians as the highest elected officers for the first time.